Target intelligence / Profile preview

SSX family member 19, pseudogene (SSX19P)

Target
SSX19P
Molecular classification
Pseudogene, Cancer-testis antigen (family association, not individual member)
01

Overview

SSX family member 19, pseudogene (SSX19P), also known as psiSSX9 or SSXP9, is classified as a pseudogene within the synovial sarcoma X breakpoint protein (SSX) family[3]. Unlike functional SSX family members (e.g., SSX1, SSX2), which are cancer-testis antigens implicated in tumor biology, SSX19P does not encode a functional protein and has no described biological activity or disease relevance[1][2][3]. It is carried as an annotation in genomics resources largely for reference and does not serve as a therapeutic target; no drug interactions or clinical biomarkers are associated with it.

Other names
psiSSX9SSXP9
02

Mechanism of action

None (as it is a pseudogene, not a drug target)

03

Biological functions

None known (SSX19P is a pseudogene and does not produce a functional protein product)
04

Disease associations

None (No disease roles have been associated specifically with SSX19P. Some functional SSX family members are implicated as cancer-testis antigens in cancer, but not pseudogenes like SSX19P)
05

Safety considerations

None (no therapeutic relevance)
06

Interacting drugs

None (as it is a pseudogene)
07

Biomarkers

None (no data or biomarker usage)

Beyond the preview

Go deeper on SSX family member 19, pseudogene (SSX19P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SSX family member 19, pseudogene (SSX19P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call